PuraMed BioScience Announces Completion of Manuscript of Clinical Study of LipiGesic(TM) M and Submission to Top-Ranked Medical Journal
SCHOFIELD, Wis., Jan. 3, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that the manuscript of the clinical study of LipiGesic™ M has been completed and has been submitted to a top-ranked medical journal for peer review.